Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Eiwegger, M. Gona, P. Fucick, A. Glaser, F. Horak, E. Nachbaur, S. Renner, S. Gruber, R. Crameri, Z. Szepfalusi, T. Frischer (Vienna, Davos, Austria). In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients. Eur Respir J 2009; 34: Suppl. 53, 476

Member's Comments

No comment yet.

Related content which might interest you: IL-10 induced T-cell tolerance to Aspergillus fumigatus and Pseudomonas aeruginosa in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 8s Year: 2001 Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis Source: Eur Respir Rev, 29 (158) 200011; 10.1183/16000617.0011-2020 Year: 2020 Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response Source: Eur Respir J 2007; 30: 1167-1172 Year: 2007 The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Source: Eur Respir J 2006; 28: 974-979 Year: 2006 Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients? Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques Year: 2018 Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model Source: Eur Respir J 2007; 29: 965-968 Year: 2007 Pulmonary infections with pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 Pseudomonas aeruginosa influences the inflammatory response of primary bronchial epithelial cells to rhinovirus infection Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Pseudomonas aeruginosa infections Source: Respipedia Article Year: 2018 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Interleukin-10 genotypes and airways colonization by Aspergillus fumigatus in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Bacterial cyanogenesis occurs in the cystic fibrosis lung Source: Eur Respir J 2008; 32: 329-333 Year: 2008 Impact of Pseudomonas aeruginosa infection on Na+ transport in airway epithelia Source: Annual Congress 2007 - The impact of viral and bacterial infection on the respiratory epithelium Year: 2007 Dysregulation of systemic and local immune response in cystic fibrosis patients with chronic P. aeruginosa infection Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by P. aeruginosa Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008